Skip to content

No results found

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

ZNTL Zentalis Pharmaceuticals, Inc. Common Stock
$2.14 2.38% +0.05
Notify me if price changes either direction
Interactive Brokers Logotype

Buy ZNTL stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 151.8M
Enterprise value -61233868
Trailing PE -0.92060085018305
Forward PE -1.2241888
PEG Ratio 0.027133498742237
Enterprise to EBITDA 0.424
Enterprise to revenue -0.90817750092696
Price to book MRQ 0.6631512
Price to sales TTM 2.2512773303671

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2025-09-30
Revenue (TTM) 67.4M
EBITDA -144272992
Diluted EPS TTM -1.91
Total Cash (MRQ) 245.9M
Current ratio (MRQ) 6.926
Operating Cash Flow (TTM) -125247000

ZNTL trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent ZNTL News

Home

No results found

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.